Indraprastha Medical (BOM:532150) Cyclically Adjusted PS Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532150 Indraprastha Medical Corp Ltd BOM:532150
79 GF Score
Price ₹367.15
GF Value ₹426.30
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Indraprastha Medical Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Indraprastha Medical  (BOM:532150) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Indraprastha Medical Cyclically Adjusted PS Ratio Related Terms


Indraprastha Medical Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Indraprastha Medical's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indraprastha Medical Cyclically Adjusted PS Ratio Chart

Indraprastha Medical Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.58 0.72 1.51 3.22 2.90

Indraprastha Medical Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.93 3.52 3.49 2.86 2.90

BOM:532150 vs HCA, THC, EHC: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, Indraprastha Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indraprastha Medical Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Indraprastha Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Indraprastha Medical's Cyclically Adjusted PS Ratio falls into.


BOM:532150
79GF Score
Indraprastha Medical Corp Ltd BOM:532150
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indraprastha Medical Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Indraprastha Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Indraprastha Medical's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=44.304/167.3573*167.3573
=44.304

Current CPI (Jun. 2026) = 167.3573.

Indraprastha Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 21.129 105.961 33.372
201612 20.807 105.196 33.102
201703 20.442 105.196 32.521
201706 20.186 107.109 31.541
201709 20.934 109.021 32.136
201712 20.263 109.404 30.997
201803 20.721 109.786 31.587
201806 20.658 111.317 31.058
201809 21.836 115.142 31.738
201812 21.620 115.142 31.424
201903 21.863 118.202 30.955
201906 22.220 120.880 30.763
201909 23.578 123.175 32.035
201912 22.954 126.235 30.431
202003 21.872 124.705 29.353
202006 10.277 127.000 13.543
202009 15.390 130.118 19.795
202012 19.636 130.889 25.107
202103 21.606 131.771 27.441
202106 22.135 134.084 27.628
202109 25.405 135.847 31.298
202112 25.810 138.161 31.264
202203 23.534 138.822 28.372
202206 28.725 142.347 33.772
202209 31.020 144.661 35.887
202212 30.208 145.763 34.683
202303 29.894 146.865 34.065
202306 33.435 150.280 37.234
202309 34.579 151.492 38.200
202312 33.430 152.924 36.585
202403 34.332 153.035 37.545
202406 37.946 155.789 40.764
202409 38.160 157.882 40.450
202412 35.444 158.323 37.467
202503 36.407 157.552 38.673
202506 39.822 159.755 41.717
202509 41.564 162.289 42.862
202512 40.536 163.281 41.548
202603 39.795 164.272 40.542
202606 44.304 167.357 44.304

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Indraprastha Medical (BOM:532150) Overvalued in 2026?

Based on GuruFocus' analysis, Indraprastha Medical stock appears to be undervalued. The current stock price of ₹367.15 is trading 13.9% below its estimated GF Value™ of ₹426.30. GuruFocus considers Indraprastha Medical to be Modestly Undervalued.

Key valuation signals for BOM:532150:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹426.30 vs. price of ₹367.15 (13.9% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the BOM:532150 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Indraprastha Medical Business Description

Other Exchanges INDRAMEDCO:India
Address Delhi-Mathura Road, Sarita Vihar, New Delhi, IND, 110 076
Indraprastha Medical Corp Ltd is an Indian company that operates in the healthcare business. It offers services in the field of anaesthesiology, pediatrics, bone marrow transplant, dental surgery, neonatology, dermatology, obesity, and metabolic surgery, orthopaedics, robotic surgery, spine surgery and in many other areas. The company also provides diagnosis, treatment, and management of various hormonal disorders; and inpatient and ambulatory care services. Geographically all the business activities of the group are carried out through the regions of India. It derives revenue from the provision of services.
79GF Score

Get the complete analysis for BOM:532150

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹367.15
Price
₹426.30
GF Value